Keytruda 100 MG/4 ML vial 4ML
Ended Awarded
- Contract number
- SPE2DB25FCMZF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,817
Award facts
- Contract value 100% obligated
- $32,816.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 3, 2025, for the supply of Keytruda 100 mg/4 ml vials. This firm fixed-price delivery order, valued at $32,816.60, is set to be completed by September 24, 2025, with performance taking place at the contractor's Park Ridge facility. The award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion single-award vehicle valid through November 2026 that authorizes the issuance of firm fixed-price orders for comprehensive pharmaceutical supplies supporting military health facilities worldwide. Keytruda, a prescription oncology medication, represents one of many specialized pharmaceutical products the contractor supplies to Department of Defense healthcare sites. DMS Pharmaceutical Group's positioning as a key supplier in the federal pharmaceutical supply chain reflects its established capability to deliver branded prescription drugs and biologics directly to military medical facilities across the nation.
Quick answers
Who was awarded contract SPE2DB25FCMZF?
SPE2DB25FCMZF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FCMZF worth?
The government has obligated $32,817 on SPE2DB25FCMZF.
Is contract SPE2DB25FCMZF an order under another contract?
Yes. SPE2DB25FCMZF is a delivery order under SPE2DB24D9144, an indefinite delivery contract.
Was contract SPE2DB25FCMZF competed?
The extent of competition for SPE2DB25FCMZF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award